Results 141 to 150 of about 12,232 (185)

PCSK9 inhibitors in the management of hypercholesterolaemia after heart transplantation in the UK, a single centre observational study. [PDF]

Sci Rep
Akhtar W, Khan T, Neves E, Browne C, Tawil M, Lyster H, Dar O.   +6 more
europepmc   +1 more source

PCSK9 Inhibitors or Cardiovascular Disease Inhibitors?

Journal of Cardiology & Cardiovascular Therapy, 2016
openaire   +1 more source

Paradoxical LDL-C Increase after Switching from PCSK9 Inhibitors to Inclisiran: A Real-World Case Series. [PDF]

Acta Cardiol Sin
Chua SK, Hung HF, Jong BH, Chen LC.
europepmc   +1 more source

Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study. [PDF]

Healthcare (Basel)
AlRuthia Y, Almutairi KK, Aljammaz NA, Alsuwayegh A, Alanazi MA, AlSulaiman RF, Alfaori TM, Alabdan N.   +7 more
europepmc   +1 more source

Hypercholesterolemia Successfully Treated With Two Different PCSK9 Inhibitors in a Patient With Glycogen Storage Disease IXd: Phosphorylase Kinase Deficiency. [PDF]

J Lipid Atheroscler
Huynh T, Nguyen H, Nguyen M.
europepmc   +1 more source

Safety and Efficacy of Achieving Very Low LDL Cholesterol Concentrations with PCSK9 Inhibitors. [PDF]

J Clin Med
Machanahalli Balakrishna A, Kaushik S, Tandalam Palanivelu S, Monther N, Ponamgi SP, Alla VM, Patil SM.   +6 more
europepmc   +1 more source

Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin Intolerance. [PDF]

Eur J Neurol
Theodorou A, Papagiannopoulou G, Akrivaki A, Fanouraki S, Moschovos C, Papadopoulou M, Palaiodimou L, Merkouri F, Melanis K, Salakou S, Kitsos D, Lambadiari V, Zouvelou V, Papadimas G, Giannopoulos S, Alexandrov AV, Tsivgoulis G.   +16 more
europepmc   +1 more source

Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis. [PDF]

J Am Heart Assoc
Zheng Y, Li Q, Yang Y, Yang J, Liu Z, Ma X, Wang Z.   +6 more
europepmc   +1 more source

Modulation of atherogenesis biomarkers by PCSK9 inhibitors in Lp(a)-stimulated human coronary artery endothelial cells. [PDF]

BMC Cardiovasc Disord
Zulkapli R, Muid SA, Wang SM, Putera Mohd Yusof MY, Nawawi H.   +4 more
europepmc   +1 more source